Alliance Global initiated coverage of Iridex (IRIX) with a Buy rating and $3 price target The ophthalmic medical technology company’s key growth drivers include the Cyclo G6 laser system for the treatment of glaucoma and the Pattern Scanning Laser System for medical-retina indications, notes the analyst, who expects strong revenue growth for both the G6 laser system and the PASCAL.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRIX: